approved EB-1A
Research Scientist-II
Microbiology And Immunology · India · 2025-03-01
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metOriginal Contributions of Major Significance (Met)
The petitioner developed virus-like particles for dengue vaccine candidates and pioneered the use of Cissampelos pareira extracts for dengue inhibition.
Authorship of Scholarly Articles (Met)
The petitioner authored 40 peer-reviewed articles and a book chapter, with research appearing in high-impact journals like PLOS Pathogens.
Judging the Work of Others (Met)
The petitioner completed over 30 peer reviews and served as an editorial board member and guest editor for several journals.
Why This Petition Was Approved
The petition was approved based on satisfying three EB-1A criteria: original contributions of major significance, authorship of scholarly articles, and judging the work of others. Metrics included 40 peer-reviewed articles (15 first-author), over 590 citations from 53 countries, and 30 peer review assignments for elite journals. The case was further strengthened by evidence of funding from the NIH and major pharmaceutical companies like Sun Pharmaceuticals and Daiichi Sankyo.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Evidence Submitted
- 40 peer-reviewed articles in journals such as JCI Insight and PLOS Pathogens
- 15 first-author publications
- Over 590 citations across 53 countries
- 3 papers ranked in the top 10% of most cited in immunology
- 1 book chapter
- 1 patent and 1 patent publication
- Over 30 peer reviews for elite journals
- Editorial board member and guest editor for Frontiers in Immunology and Vaccines
Similar Cases
Research Scientist
Biotechnology · India
WeGreened EB-1A approved
Massachusetts 17 days 2025-01-24
The petition was approved based on a strong record of 44 peer-reviewed journal articles and 4,450 citations, demonstrating significant influence in the field. The petitioner also provided evidence of 26 peer reviews for scientific journals and international media coverage of his findings. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.
Postdoctoral Researcher
Biotechnology · Iran
WeGreened EB-1A approved
Texas 15 days 2025-05-13
The petition was approved based on 7 peer-reviewed journal articles and 377 citations from researchers in 56 countries. The applicant demonstrated her expert status through 40 completed peer reviews for scientific journals. Additionally, her ranking in the top 1% of highly cited researchers in vaccine therapy and international funding support from the Biotechnology Development Council of Iran satisfied the EB-1A criteria.
Postdoctoral Researcher
Biotechnology · India
WeGreened EB-1A approved
Pennsylvania 836 days 2026-01-21
The petition was approved based on a record of 17 peer-reviewed articles and 1,210 citations, demonstrating extensive independent reliance by the research community. The petitioner also provided evidence of 13 completed manuscript reviews for respected journals. Approval was further supported by original contributions in structure-guided HIV vaccine design and nucleic acid-based strategies for SARS-CoV-2.
Research Scientist
Biotechnology · China
WeGreened EB-1A approved
369 days 2025-01-15
The petition was approved based on the petitioner's 47 peer-reviewed publications in top-tier journals and a high citation count of 2,811. Additionally, her 48 journal reviews served as evidence of her judging the work of others. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging roles.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-01.
Browse all casesAt a Glance
Outcome approved
Processing 396 days
Criteria Met 3 / 3
Evidence Types 7
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist